BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35151346)

  • 21. Vps33b pathogenic mutations preferentially affect VIPAS39/SPE-39-positive endosomes.
    Tornieri K; Zlatic SA; Mullin AP; Werner E; Harrison R; L'hernault SW; Faundez V
    Hum Mol Genet; 2013 Dec; 22(25):5215-28. PubMed ID: 23918659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome.
    Cullinane AR; Straatman-Iwanowska A; Seo JK; Ko JS; Song KS; Gizewska M; Gruszfeld D; Gliwicz D; Tuysuz B; Erdemir G; Sougrat R; Wakabayashi Y; Hinds R; Barnicoat A; Mandel H; Chitayat D; Fischler B; Garcia-Cazorla A; Knisely AS; Kelly DA; Maher ER; Gissen P
    Hum Mutat; 2009 Feb; 30(2):E330-7. PubMed ID: 18853461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report.
    Rosales A; Mhibik M; Gissen P; Segarra O; Redecillas S; Ariceta G
    BMC Nephrol; 2018 Jun; 19(1):144. PubMed ID: 29907094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel VPS33B Mutation Causing a Mild Phenotype of Arthrogryposis, Renal dysfunction, and Cholestasis Syndrome.
    Agawu A; Sheppard S; Lin HC
    J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):e55-e56. PubMed ID: 31343487
    [No Abstract]   [Full Text] [Related]  

  • 25. A Novel VPS33B Mutation in a Patient with Arthrogryposis-Renal Dysfunction-Cholestasis Syndrome.
    Moon AT; Christensen T; Streicher JL; Castelo-Soccio L
    Pediatr Dermatol; 2017 Jul; 34(4):e171-e173. PubMed ID: 28544027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VPS33B mutation with ichthyosis, cholestasis, and renal dysfunction but without arthrogryposis: incomplete ARC syndrome phenotype.
    Bull LN; Mahmoodi V; Baker AJ; Jones R; Strautnieks SS; Thompson RJ; Knisely AS
    J Pediatr; 2006 Feb; 148(2):269-71. PubMed ID: 16492441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and molecular genetic features of ARC syndrome.
    Gissen P; Tee L; Johnson CA; Genin E; Caliebe A; Chitayat D; Clericuzio C; Denecke J; Di Rocco M; Fischler B; FitzPatrick D; García-Cazorla A; Guyot D; Jacquemont S; Koletzko S; Leheup B; Mandel H; Sanseverino MT; Houwen RH; McKiernan PJ; Kelly DA; Maher ER
    Hum Genet; 2006 Oct; 120(3):396-409. PubMed ID: 16896922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The complex phenotype of ARC syndrome: A new case].
    Giraud A; Ramond F; Cremillieux C; Touraine R; Patural H; Stephan JL
    Arch Pediatr; 2017 Feb; 24(2):131-134. PubMed ID: 28007512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome.
    Gissen P; Johnson CA; Morgan NV; Stapelbroek JM; Forshew T; Cooper WN; McKiernan PJ; Klomp LW; Morris AA; Wraith JE; McClean P; Lynch SA; Thompson RJ; Lo B; Quarrell OW; Di Rocco M; Trembath RC; Mandel H; Wali S; Karet FE; Knisely AS; Houwen RH; Kelly DA; Maher ER
    Nat Genet; 2004 Apr; 36(4):400-4. PubMed ID: 15052268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A New Aberration in the VPS33B Gene Leads to Full-Symptom ARCS1.
    Adamczyk-Gruszka O; Horecka-Lewitowicz A; Zmelonek-Znamirowska A; Gruszka J; Koziel D; Lewitowicz P
    Am J Case Rep; 2021 Sep; 22():e932769. PubMed ID: 34531360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orthopaedic manifestations of arthrogryposis-renal dysfunction-cholestasis syndrome.
    Jang WY; Cho TJ; Bae JY; Jung HW; Ko JS; Park MS; Yoo WJ; Chung CY; Seo JK; Choi IH
    J Pediatr Orthop; 2011; 31(1):107-12. PubMed ID: 21150740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Platelets and ε-Aminocaproic Acid in Arthrogryposis, Renal Dysfunction, and Cholestasis (ARC) Syndrome Associated Hemorrhage.
    Weyand AC; Lombel RM; Pipe SW; Shavit JA
    Pediatr Blood Cancer; 2016 Mar; 63(3):561-3. PubMed ID: 26505894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective lamellar granule secretion in arthrogryposis, renal dysfunction, and cholestasis syndrome caused by a mutation in VPS33B.
    Hershkovitz D; Mandel H; Ishida-Yamamoto A; Chefetz I; Hino B; Luder A; Indelman M; Bergman R; Sprecher E
    Arch Dermatol; 2008 Mar; 144(3):334-40. PubMed ID: 18347289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel VPS33B mutation in a patient with autosomal recessive keratoderma-ichthyosis-deafness syndrome.
    Alter S; Hotz A; Jahn A; Di Donato N; Schröck E; Smitka M; von der Hagen M; Schallner J; Menschikowski M; Gillitzer C; Laass MW; Fischer J; Tzschach A
    Am J Med Genet A; 2018 Dec; 176(12):2862-2866. PubMed ID: 30561130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arthrogryposis-renal tubular dysfunction-cholestasis syndrome: a cause of neonatal cholestasis. Case report.
    Ilhan O; Ozer EA; Ozdemir SA; Akbay S; Memur S; Kanar B; Tatli MM
    Arch Argent Pediatr; 2016 Feb; 114(1):e9-12. PubMed ID: 26914089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An uncommon case of arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome and review of the renal involvement: Questions.
    Duong MD; Rose CM; Reidy KJ; Del Rio M
    Pediatr Nephrol; 2020 Feb; 35(2):247-248. PubMed ID: 31463585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function.
    Rogerson C; Gissen P
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1609-1621. PubMed ID: 29409756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ARC syndrome in preterm baby.
    Elmeery A; Lanka K; Cummings J
    J Perinatol; 2013 Oct; 33(10):821-2. PubMed ID: 24071963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel
    Lee MJ; Suh CR; Shin JH; Lee JH; Lee Y; Eun BL; Yoo KH; Shim JO
    Pediatr Gastroenterol Hepatol Nutr; 2019 Nov; 22(6):581-587. PubMed ID: 31777725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization.
    Cullinane AR; Straatman-Iwanowska A; Zaucker A; Wakabayashi Y; Bruce CK; Luo G; Rahman F; Gürakan F; Utine E; Ozkan TB; Denecke J; Vukovic J; Di Rocco M; Mandel H; Cangul H; Matthews RP; Thomas SG; Rappoport JZ; Arias IM; Wolburg H; Knisely AS; Kelly DA; Müller F; Maher ER; Gissen P
    Nat Genet; 2010 Apr; 42(4):303-12. PubMed ID: 20190753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.